Citation

85 FR 326

Canonical document for this Federal Register citation.

Prospective Grant of an Exclusive Patent License: Use of the CD47 Phosphorodiamidate Morpholino Oligomers for the Treatment, Prevention, and Diagnosis of Solid Tumors Friday, January 3, 2020 85 FR 326